Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
FDA Clears First Targeted Dermatomyositis Treatment From Roivant ↗
Via Benzinga
Exposures Product Safety
News headline image
Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment ↗
Via MarketBeat
Tickers PTGX
Exposures Product Safety
News headline image
Cytokinetics Investors Weigh Safety Data From Pivotal Trial ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Approves Gilead's New Single Tablet HIV Regimen ↗
Via Benzinga
Tickers GILD
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Measles Treatment Program Toward Phase II Trial
Via Investor Brand Network
Topics Intellectual Property
Tickers NNVC
Exposures COVID-19 Intellectual Property Product Safety
NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Concussion Trial, Provides FDA and Listing Updates
Via Investor Brand Network
Tickers OGEN
Exposures Product Safety
News headline image
Navigating US FDA Post-Market Compliance and Pharmacovigilance in 2026 ↗
Via Talk Markets
Exposures Product Safety
News headline image
Generative AI in Clinical Trial Market: Size, Trends, and Strategic Insights to 2033 ↗
Via Talk Markets
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Product Safety Supply Chain
News headline image
KDL Disposable Enteral Oral Feeding Syringe
Via AB Newswire
Exposures Product Safety
News headline image
Bulk Customization Solution for Sustainable EcoFriendly Gifts
Via AB Newswire
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Markets and clients – Industry Trends and Best Practices
Via AB Newswire
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. (CAPR) Action Lawsuit: Investors Face September 28, 2026, Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
Crypto News: Pepeto Announces Its DeFi Toolkit While Bitcoin Price Prediction Hits $250,000
Via First Publisher
Topics Product Recall
Exposures Legal Product Safety
TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Advances Global Robotic Surgery Strategy with SSi Mantra Platform
Via Investor Brand Network
Topics Artificial Intelligence
Tickers SSII
Exposures Artificial Intelligence Product Safety
News headline image
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer ↗
Via MarketBeat
Tickers RVMD
Exposures Product Safety
News headline image
Roivant Sciences Wins FDA Approval for LISRAYA in Dermatomyositis, Launches Immediately ↗
Via MarketBeat
Topics Government
Tickers ROIV
Exposures Political Product Safety
News headline image
72 Million Vehicles Have an Open Automotive Recall: Recall Wire News Launches an AI-Native Platform to Make That Information Usable for Every Driver
Via Press Release Distribution Service
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
News headline image
Cytokinetics’ Aficamten Hits Dual Phase III Endpoints in Non-Obstructive HCM ↗
Via MarketBeat
Tickers CYTK
Exposures Product Safety
News headline image
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
SS Innovations International Inc. (NASDAQ: SSII) Indian Surgical Robotics Growth Points to Broader Market Opportunity
Via Investor Brand Network
Tickers SSII
Exposures Product Safety
News headline image
REHACARE CHINA concluded on a high note, heralding a new era for rehabilitation and senior care
Via Get News
Exposures Product Safety
News headline image
Why Lucid Stock Is Sinking This Week ↗
Via The Motley Fool
Topics Electric Vehicles Government Product Recall
Tickers LCID
Exposures Electric Vehicles Legal Political
News headline image
Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X? ↗
Via The Motley Fool
Tickers RVMD
Exposures Product Safety
News headline image
Paysign Targets $117M Revenue as Patient-Affordability Business Surges ↗
Via MarketBeat
Tickers PAYS
Exposures Product Safety
News headline image
University Findings Undermine Core Electrical Theory Behind Electroshock Therapy—Prompting CCHR's Renewed Calls for a Ban
Via 24-7 Press Release
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.